↓ Skip to main content

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
49 Mendeley
Title
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer
Published in
Breast Cancer Research and Treatment, November 2012
DOI 10.1007/s10549-012-2296-x
Pubmed ID
Authors

Karin Milde-Langosch, Thomas Karn, Volkmar Müller, Isabell Witzel, Achim Rody, Markus Schmidt, Ralph M. Wirtz

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 48 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 16%
Student > Ph. D. Student 7 14%
Student > Bachelor 6 12%
Unspecified 5 10%
Student > Master 5 10%
Other 11 22%
Unknown 7 14%
Readers by discipline Count As %
Medicine and Dentistry 10 20%
Biochemistry, Genetics and Molecular Biology 10 20%
Agricultural and Biological Sciences 8 16%
Unspecified 5 10%
Mathematics 1 2%
Other 5 10%
Unknown 10 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2019.
All research outputs
#4,488,844
of 22,685,926 outputs
Outputs from Breast Cancer Research and Treatment
#830
of 4,618 outputs
Outputs of similar age
#34,083
of 183,504 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#22
of 66 outputs
Altmetric has tracked 22,685,926 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,618 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,504 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.